Fixed-dose combination capsules containing HMG-CoA reductase inhibitor and antiplatelet agent, used in cardiovascular disease management protocols. Manufactured by generic pharmaceutical firms, supplied through B2B channels to hospitals, cardiology clinics, and retail pharmacies for procurement by healthcare providers and distributors.